Tivic Health Systems, Inc. (TIVC): Price and Financial Metrics

Tivic Health Systems, Inc. (TIVC): $1.95

0.10 (+5.41%)

POWR Rating

Component Grades













TIVC Stock Price Chart Interactive Chart >

Price chart for TIVC

TIVC Price/Volume Stats

Current price $1.95 52-week high $6.50
Prev. close $1.85 52-week low $1.23
Day low $1.80 Volume 57,122
Day high $2.03 Avg. volume 180,980
50-day MA $1.80 Dividend yield N/A
200-day MA $0.00 Market Cap 18.76M

Tivic Health Systems, Inc. (TIVC) Company Bio

Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. The company's primary product, ClearUP, is a medical device intended to relieve sinus and nasal inflammation. It sells its products on direct-to-consumer channel through its own websites and platforms, such as Amazon.com, as well as to major U.S. online retailers, such as BestBuy.com, FSAStore.com, Walgreens.com, Walmart.com. The company was incorporated in 2016 and is headquartered in Newark, California.

TIVC Latest News Stream

Event/Time News Detail
Loading, please wait...

TIVC Latest Social Stream

Loading social stream, please wait...

View Full TIVC Social Stream

Latest TIVC News From Around the Web

Below are the latest news stories about Tivic Health Systems Inc that investors may wish to consider to help them evaluate TIVC as an investment opportunity.

Tivic Health’s ClearUP Named Best Sinus Pain Relief Solution of 2021 by Global Health & Pharma Magazine

SAN FRANCISCO, February 07, 2022--Tivic Health's ClearUP named Best Sinus Pain Relief Solution of 2021 by Global Health & Pharma Magazine.

Yahoo | February 7, 2022

Tivic Featured in ABC News Report: "New Bioelectronic Technologies Could Signal the Future of Medicine"

SAN FRANCISCO, January 31, 2022--Tivic Health (TIVC) was one of two companies featured in the ABC News story "New Bioelectronic Technologies Could Signal the Future of Medicine."

Yahoo | January 31, 2022

Tivic Health Collaborates With Leading Medical Research Hospital on First Controlled Trial to Extend Tivic’s Bioelectronic Platform

SAN FRANCISCO, January 19, 2022--Tivic Health announces trial with research hospital to investigate bioelectronic therapeutic device as alternative to opioids after sinus surgeries.

Yahoo | January 19, 2022

Tivic Health Names Mindgruve Digital Marketing Agency of Record

SAN FRANCISCO, December 20, 2021--Tivic Health (Nasdaq: TIVC) names Mindgruve as its digital marketing agency of record.

Yahoo | December 20, 2021

Tivic Health Named to Fast Company’s Inaugural Next Big Things in Tech

SAN FRANCISCO, December 08, 2021--Tivic Health named to Fast Company's Next Big Things in Tech. CEO Jennifer Ernst receives Inc's 2021 Female Founders 100 award.

Yahoo | December 8, 2021

Read More 'TIVC' Stories Here

TIVC Price Returns

1-mo 3.72%
3-mo 25.00%
6-mo -39.25%
1-year N/A
3-year N/A
5-year N/A
YTD -49.74%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.4146 seconds.